Alzheimer's disease is the most common cause of dementia, and it affects over 7 million people in the United States alone.

Researchers say they are now able to predict Alzheimer’s disease with close to 93 percent accuracy using artificial ...

New paper from UC Santa Cruz chemistry lab argues that efforts to develop treatments for Alzheimer's should stop ignoring a short protein called P3, the ‘neglected cousin’ of amyloid beta ...

In people destined to get Alzheimer's in their mid-40s, one protein can delay the onset of the disease by about 20 years.

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

More than 7 million Americans currently have Alzheimer’s disease (AD). That’s according to the Alzheimer’s Association. One out of every nine seniors over age 65 will experience some degree of ...

A new blood test could replace the brain scans and spinal taps currently used to diagnose Alzheimer's disease.

Conductor Juanjo Mena, former principal conductor of the Cincinnati May Festival, says he will retire this year because of Alzheimer’s disease.

WPI researchers use machine learning and brain scans to identify age- and sex-specific anatomical patterns that predict ...

Learn about comparative gene expression studies in Alzheimer's disease and other conditions in Mayo Clinic's Precision Medicine in Neurodegeneration Lab.

Each monthly installment examines an aspect of Alzheimer's disease care, including making and delivering the diagnosis; ...

Taner, M.D., Ph.D., who leads Mayo Clinic's Precision Medicine in Neurodegeneration Lab, studies complex genetic interactions in Alzheimer's disease.